HEALTH OF WOMAN. 2016.5(112):131–133 
 

HPV infection and vaginal microbiota 
 

Rudakova E. B.

GUZ of Moscow regional perinatal center, Balashikha

Opublikovano v zhurnale: «Lechaschiy vrach», 2012, №3, S. 38–40.

REFERENCES

1. Budanov PV, Voronoy SV, Aslanov AG. 2004. Printsipyi lecheniya papillomavirusnoy infektsii. Vopr. ginekol., akush., perinatal. 3;4:70–75.

2. Isakov VA, Ermolenko DK, Kutueva FR i soavt. 2007. Ispolzovanie tsikloferona v terapii papillomavirusnoy infektsii. Rekomendatsii dlya vrachey. SPb–Velikiy Novgorod:64.

3. Kiselev VI. 2004. Virusyi papillomyi cheloveka v razvitii raka sheyki matki. M, Kompaniya «Dimitreyd Grafik Grupp»:180.

4. Kondrikov NI. 2008. Patologiya matki. M, Prakticheskaya meditsina.

5. Krasnopolskiy VI i soavt. 2011. Papillomavirusnaya infektsiya u devochek: Informatsionno-metodicheskoe pismo. M:31.

6. Kulakov VI, Paavonen Y, Prilepskaya VN. 2008. Profilaktika raka sheyki matki: Rukovodstvo dlya vrachey. M.

7. Prilepskaya VP, Rogovskaya SI. 2007. Vozmozhnosti Izoprinozina v lechenii hronicheskih tservitsitov i vaginitov. RMZh. 16;3:5–9.

8. Redkin YuV, Baturova OG. 2008. Klinicheskaya effektivnost kombinatsii preparatov panavir i indinol v lechenii zhenschin s papillomavirusnoy infektsiey. Terra medica Nova 2:36–41.

9. Shvarts TYa, Prilepskaya VP, Myinbaev OA. 2011. Izoprinozin v lechenii papillomavirusnoy infektsii v ginekologicheskoy praktike. M:83.

10. Ocnishi П, Kosuzume П, Inaba H et al. 1982. Mehanizm of host defens suppression induced by viral infection: mode of action of Inosimplex as an antiviral agent. Infect.Immun. 38(1):245–250.